AVDL — AVADEL PHARMACEUTICALS PLC

Ownership history in WEALTH EFFECTS LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which WEALTH EFFECTS LLC reported a position in AVADEL PHARMACEUTICALS PLC (AVDL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
17.18% (2023 Q2)
Avg. % of fund
10.33%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,891,917 -396,896 -17.3% 12.75% $40.8M $21.55
2025 Q3 REDUCED 2,288,813 -66,009 -2.8% 11.24% $35.0M $15.27
2025 Q2 REDUCED 2,354,822 -14,300 -0.6% 7.80% $20.8M $8.85
2025 Q1 ADDED 2,369,122 +24,992 +1.1% 7.79% $18.6M $7.83
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AVDL price (monthly, adj. close)

Other funds also holding AVDL

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 6.51% Knoll Capital Management, LLC 3Y 7Y 5.93% KOTLER KEVIN 4.43% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 4.26% TIG Advisors, LLC 3Y 7Y 3.85% Vivo Capital, LLC 3Y 7Y 3.74% KOTLER KEVIN 3.74% WATER ISLAND CAPITAL LLC 3Y 7Y 2.53% HARVEST MANAGEMENT LLC 3Y 7Y 2.07% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 2.06%
← Back to WEALTH EFFECTS LLC Holdings